Hualan Biological Vaccine Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2017
Period Ending	Nov '24 Nov 14, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2017
Market Capitalization	11,710	16,680	17,832	-	-	-	Upgrade
Market Cap Growth	-39.00%	-6.46%	-	-	-	-	Upgrade
Enterprise Value	9,471	14,346	15,905	-	-	-	Upgrade
Last Close Price	19.68	26.92	28.61	-	-	-	Upgrade
PE Ratio	23.80	18.86	32.50	-	-	-	Upgrade
Forward PE	12.72	15.22	17.00	-	-	-	Upgrade
PS Ratio	7.16	6.92	9.77	-	-	-	Upgrade
PB Ratio	1.92	2.66	3.24	-	-	-	Upgrade
P/TBV Ratio	2.05	2.67	3.26	-	-	-	Upgrade
P/FCF Ratio	16.85	20.21	90.97	-	-	-	Upgrade
P/OCF Ratio	16.59	18.78	61.78	-	-	-	Upgrade
EV/Sales Ratio	5.74	5.95	8.71	-	-	-	Upgrade
EV/EBITDA Ratio	16.06	14.03	24.91	-	-	-	Upgrade
EV/EBIT Ratio	21.29	16.27	31.55	-	-	-	Upgrade
EV/FCF Ratio	13.63	17.38	81.14	-	-	-	Upgrade
Debt / Equity Ratio	0.05	0.05	0.05	0.18	0.09	-	Upgrade
Debt / EBITDA Ratio	0.51	0.29	0.47	0.68	0.18	-	Upgrade
Debt / FCF Ratio	0.43	0.36	1.53	-	1.24	-	Upgrade
Asset Turnover	0.21	0.32	0.31	0.45	0.89	0.66	Upgrade
Inventory Turnover	1.36	2.24	2.69	4.64	5.71	3.14	Upgrade
Quick Ratio	2.83	2.73	2.57	1.43	1.65	2.25	Upgrade
Current Ratio	3.08	3.10	2.73	1.51	1.69	2.38	Upgrade
Return on Equity (ROE)	8.21%	14.63%	12.51%	24.86%	53.63%	34.93%	Upgrade
Return on Assets (ROA)	3.60%	7.32%	5.43%	10.28%	24.23%	16.29%	Upgrade
Return on Capital (ROIC)	4.37%	8.92%	6.92%	14.75%	36.13%	23.96%	Upgrade
Earnings Yield	4.20%	5.16%	2.91%	-	-	-	Upgrade
FCF Yield	5.94%	4.95%	1.10%	-	-	-	Upgrade
Dividend Yield	2.98%	2.23%	0.70%	-	-	-	Upgrade
Payout Ratio	67.83%	14.66%	17.49%	2.06%	0.50%	-	Upgrade
Buyback Yield / Dilution	-0.21%	-2.03%	-9.33%	-0.00%	0.24%	-0.19%	Upgrade
Total Shareholder Return	2.77%	0.20%	-8.63%	-0.00%	0.24%	-0.19%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.